Inspire Medical Systems, Inc.
General ticker "INSP" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.0B (TTM average)
Inspire Medical Systems, Inc. does not follow the US Stock Market performance with the rate: -12.8%.
Estimated limits based on current volatility of 1.9%: low 68.21$, high 70.86$
Factors to consider:
- Total employees count: 1333 (+7.0%) as of 2025
- US accounted for 95.6% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Sustain profitability, Market acceptance, Product development failure, Regulatory and compliance, Inventory management
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [64.47$, 123.12$]
- 2026-12-31 to 2027-12-31 estimated range: [65.62$, 122.85$]
Financial Metrics affecting the INSP estimates:
- Negative: with PPE of 36.7 at the end of fiscal year the price was high
- Positive: 4.60 < Operating profit margin, % of 5.59
- Positive: 2.37 < Operating cash flow per share per price, % of 4.21
- Negative: Investing cash flow per share per price, % of 0.77 <= 2.08
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Shareholder equity ratio, % of 86.10 > 81.92
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
Short-term INSP quotes
Long-term INSP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $624.80MM | $802.80MM | $911.98MM |
| Operating Expenses | $665.07MM | $766.72MM | $861.03MM |
| Operating Income | $-40.27MM | $36.08MM | $50.95MM |
| Non-Operating Income | $20.36MM | $22.37MM | $14.74MM |
| Interest Expense | $0.00MM | $0.02MM | $0.14MM |
| R&D Expense | $116.54MM | $114.13MM | $103.17MM |
| Income(Loss) | $-19.91MM | $58.45MM | $65.70MM |
| Taxes | $1.25MM | $4.94MM | $-79.72MM |
| Net Income(Loss)* | $-21.15MM | $53.51MM | $145.42MM |
| Stockholders Equity | $572.51MM | $689.70MM | $781.16MM |
| Inventory | $33.88MM | $80.12MM | $145.29MM |
| Assets | $676.81MM | $808.38MM | $907.32MM |
| Operating Cash Flow | $24.65MM | $130.25MM | $116.98MM |
| Capital expenditure | $23.63MM | $39.12MM | $38.50MM |
| Investing Cash Flow | $-294.82MM | $-113.12MM | $21.45MM |
| Financing Cash Flow | $13.95MM | $-52.39MM | $-183.45MM |
| Earnings Per Share** | $-0.72 | $1.80 | $4.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.